Evidence map›Paper›PMID 39039282›Full record

SynthesisNature genetics2024

Genome-wide association meta-analysis identifies five loci associated with postpartum hemorrhage.

David Westergaard, Valgerdur Steinthorsdottir, Lilja Stefansdottir, Palle Duun Rohde, Xiaoping Wu, Frank Geller, Jaakko Tyrmi, Aki S Havulinna, Pol Solé-Navais, Christopher Flatley and 35 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Postpartum Hemorrhage: A Comprehensive Review of Medical and Surgical Treatment.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2026
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

David WestergaardDepartment of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.ORCID http://orcid.org/0000-0003-0128-8432
Valgerdur SteinthorsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-1846-6274
Lilja StefansdottirdeCODE genetics/Amgen, Reykjavik, Iceland.
Palle Duun RohdeDepartment of Health Science and Technology, Aalborg University, Gistrup, Denmark.ORCID http://orcid.org/0000-0003-4347-8656
Xiaoping WuDepartment of Clinical immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-7844-1397
Frank GellerDepartment of Clinical immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-9238-3269
Jaakko TyrmiCentre for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Aki S HavulinnaInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Pol Solé-NavaisDepartment of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-3326-266X
Christopher FlatleyDepartment of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-2225-0188
Sisse Rye OstrowskiDepartment of Clinical immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5288-3851
Ole Birger PedersenDepartment of Clinical medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-2312-5976
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-6551-6647
Erik SørensenDepartment of Clinical immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Christina MikkelsenDepartment of Clinical immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-2945-6197
Mie Topholm BruunClinical Immunological Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0002-8819-5388
Bitten Aagaard JensenDepartment of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Thorsten BrodersenDepartment of Clinical immunology, Zealand University Hospital, Køge, Denmark.ORCID http://orcid.org/0000-0003-4431-9972
Henrik UllumDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
FinnGen
Danish Blood Donor Study Genomic Consortium
Estonian Biobank Research Team
Nordic Collaboration for Womens and Reproductive Health
Per MagnusDepartment of Genetics and Bioinformatics, Health Data and Digitalization, Norwegian Institute of Public Health, Oslo, Norway.ORCID http://orcid.org/0000-0002-6427-4735
Ole A AndreassenNORMENT Centre, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-4461-3568
Pål R NjolstadMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-0304-6728
Astrid Marie KolteDepartment of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Lone KrebsDepartment of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.ORCID http://orcid.org/0000-0001-5433-4776
Mette NyegaardDepartment of Health Science and Technology, Aalborg University, Gistrup, Denmark.ORCID http://orcid.org/0000-0003-4973-8543
Thomas Folkmann HansenNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6703-7762
Bjarke FeenstraDepartment of Clinical immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1478-649X
Mark DalyInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Cecilia M LindgrenBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Gudmar ThorleifssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-4623-9087
Olafur A StefanssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-9663-3018
Gardar SveinbjornssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-2429-9468
Daniel F GudbjartssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.
Karina BanasikDepartment of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Bo JacobssonDepartment of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-5079-2374
Triin LaiskEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0003-1501-9030
Hannele LaivuoriCentre for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID http://orcid.org/0000-0003-3212-7826
Kari StefanssondeCODE genetics/Amgen, Reykjavik, Iceland.
Søren BrunakNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Soren.brunak@cpr.ku.dk.ORCID http://orcid.org/0000-0003-0316-5866
Henriette Svarre NielsenDepartment of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. Henriette.svarre.nielsen@regionh.dk.ORCID http://orcid.org/0000-0003-2106-8103

Funding

Integrating genomic studies of gestational duration and birth weight to understand maternal and fetal causes of adverse pregnancy outcomes and links with later diseasesR01HD101669 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI FREATHY, RACHEL, JACOBSSON, BO · 2021 to 2024
$2.1M
NICHD NIH HHS R01 HD101669Novo Nordisk Fonden (Novo Nordisk Foundation) NNF14CC0001Novo Nordisk Fonden (Novo Nordisk Foundation) NNF17OC0027594
6 · The paper itself

Abstract

Bleeding in early pregnancy and postpartum hemorrhage (PPH) bear substantial risks, with the former closely associated with pregnancy loss and the latter being the foremost cause of maternal death, underscoring the severe impact on maternal-fetal health. We identified five genetic loci linked to PPH in a meta-analysis. Functional annotation analysis indicated candidate genes HAND2, TBX3 and RAP2C/FRMD7 at three loci and showed that at each locus, associated variants were located within binding sites for progesterone receptors. There were strong genetic correlations with birth weight, gestational duration and uterine fibroids. Bleeding in early pregnancy yielded no genome-wide association signals but showed strong genetic correlation with various human traits, suggesting a potentially complex, polygenic etiology. Our results suggest that PPH is related to progesterone signaling dysregulation, whereas early bleeding is a complex trait associated with underlying health and possibly socioeconomic status and may include genetic factors that have not yet been identified.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotidePostpartum HemorrhageFemaleGenetic LociGenetic Predisposition to DiseaseHumansPregnancyReceptors, ProgesteroneReceptors, Progesterone

Identifiers

PMID39039282
PMCPMC11319197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.